Phase Ib-II study of ramucirumab combined with nab-paclitaxel and Gemcitabine as first-line treatment in patients with advanced pancreatic adenocarcinoma (RACING)

Cancer Treatment and Research Communications · Elsevier

Аннотация

Publication date: 2026 Source: Cancer Treatment and Research Communications, Volume 49 Author(s): George Papaxoinis, Joseph Sgouros, Nikolaos Korfiatis, Kyriaki Papadopoulou, Amanda Psyrri, Georgios Zarkavelis, Alexandros Ioannou, Georgios Petrakis, Ioannis Kotsantis, Anna Koumarianou, Elena Fountzilas, Flora Zagouri, Epaminondas Samantas, George Fountzilas, George Pentheroudakis

Читать у издателя →

Похожие статьи